Biography
Dr. Melissa H. Coleman obtained her undergraduate degree in Biology at Harvard College and her medical degree at Weill Cornell Medical College. Dr. Coleman began her General Surgery Residency at Duke University Medical Center where she completed her intern and second year. From 2009 – 2011 she was a research fellow in the Thoracic Surgery Oncology Laboratory at Brigham and Women's Hospital under the direction of Dr. Raphael Bueno, Chief of the Division of Thoracic Surgery. Her research focused on the identification of estrogen-regulated genes associated with malignant pleural mesothelioma outcomes. Dr. Coleman then completed her General Surgery Residency followed by a Surgical Critical Care and Clinical Nutrition Fellowship at Brigham and Women's Hospital. She subsequently completed a fellowship in Thoracic Surgery at UCSF. Dr. Coleman was awarded the UCSF Exceptional Physician Award in her final year as a Thoracic Surgery Fellow.
After graduation, Dr. Coleman joined the faculty at UCSF. Her clinical practice includes general thoracic surgery with a focus on thoracic oncology, robotic thoracic surgery, and surgical management of hyperhidrosis. In addition to her role as a Thoracic Surgeon, she practices critical care medicine and has a focus on medical education.
In 2021, Dr. Coleman was named a John A. Watson Faculty Scholar, an honor that confers a grant from the UCSF Dean's Diversity Fund. Dr. Coleman developed the UCSF Thoracic Surgery Fellowship curriculum and is currently pursuing research focused on learning strategies in graduate medical education. She received the 2020 UCSF Thoracic Residency Program Teaching Award, earned the UCSF Haile T. Debas Academy of Medical Educators Excellence in Teaching Award 2021 and completed the UCSF Teaching Scholars Program in 2023. Dr. Coleman is also the Director of UCSF School of Medicine Clinical Immersive Experiences (CIEx) program.
After graduation, Dr. Coleman joined the faculty at UCSF. Her clinical practice includes general thoracic surgery with a focus on thoracic oncology, robotic thoracic surgery, and surgical management of hyperhidrosis. In addition to her role as a Thoracic Surgeon, she practices critical care medicine and has a focus on medical education.
In 2021, Dr. Coleman was named a John A. Watson Faculty Scholar, an honor that confers a grant from the UCSF Dean's Diversity Fund. Dr. Coleman developed the UCSF Thoracic Surgery Fellowship curriculum and is currently pursuing research focused on learning strategies in graduate medical education. She received the 2020 UCSF Thoracic Residency Program Teaching Award, earned the UCSF Haile T. Debas Academy of Medical Educators Excellence in Teaching Award 2021 and completed the UCSF Teaching Scholars Program in 2023. Dr. Coleman is also the Director of UCSF School of Medicine Clinical Immersive Experiences (CIEx) program.
Awards & Honors
Award | Conferred By | Date |
---|---|---|
Academy of Medical Educators Excellence in Teaching Award | Haile T. Debas Academy of Medical Educators, UCSF | 2021 |
John A. Watson Faculty Scholar, Dean’s Diversity Fund Award | UCSF School of Medicine | 2021 |
UCSF Thoracic Residency Program Teaching Award | UCSF | 2020 |
UCSF Health Exceptional Physician Award | UCSF | 2019 |
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
UCSF | Cardiothoracic Surgery Fellowship | 2019 | |
Brigham and Women's Hosptial | Clinical Nutrition Fellowship | 2016 | |
Brigham and Women's Hosptial | Surgical Critical Care Fellowship | 2015 | |
Brigham and Women's Hospital | General Surgery Residency | 2014 | |
Weill Cornell Medical School | MD | 2007 | |
Harvard University | AB | Biology | 2002 |
Board Certifications
American Board of Thoracic Surgery
American Board of Surgery, Surgery
American Board of Surgery, Surgical Critical Care
Foreign Languages Spoken
English
Program Affiliations
UCSF Helen Diller Comprehensive Cancer Center
UCSF Thoracic Surgery & Oncology Program
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 11
- CHEST Critical Care| | View in PubMed
- Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.| | View in PubMed
- Large Language Model-Based Chatbot vs Surgeon-Generated Informed Consent Documentation for Common Procedures.| | View in PubMed
- I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.| | View in PubMed
- Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.| | View in PubMed
- Acute Respiratory Distress Syndrome: Ventilator Management and Rescue Therapies.| | View in PubMed
- Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma.| | View in PubMed
- Tourniquet Use in a Civilian Emergency Medical Services Setting: A Descriptive Analysis of the Boston EMS Experience.| | View in PubMed
- Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.| | View in PubMed
- Role of adjuvant chemotherapy in NSCLC (stages I to III).| | View in PubMed
- Laparoscopic closure of the Petersen mesenteric defect.| | View in PubMed